- Research Digest
Learn how investigators leverage the golden hamster model system to understand adaptive immune memory responses to SARS-CoV-2 and VOC.
01-17-2022Read More »
Researchers from Oslo University Hospital recently found an appealing cancer target named TdT for short, providing new "eyes" of immune system to detect cancer cells.
01-09-2022Read More »
Various vaccines based on different types of RNA are now under development to fight emerging SARS-CoV-2 variants, bringing new hopes for stopping the long-standing pandemic.
09-28-2021Read More »
Off-target effects remain a major concern in CRISPR-mediated immunotherapies. Read on and learn how a chemical toolbox can be developed in an effort to overcome this problem.
09-16-2021Read More »
The development of numerous vaccines against SARS-CoV-2 worldwide within one year of the pandemic is unprecedented and undoubtedly a huge accomplishment in human history.
08-18-2021Read More »
The study reveals the capacity of lymphangiogenic vaccines to promote a potent anti-cancer T cell immunity, and suggests a new protective and therapeutic approach to fight solid tumors.
07-22-2021Read More »
Rana, Jyoti, et al. "CAR and TRuC redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII." Molecular Therapy (2021).
06-09-2021Read More »
Liu, Yinghui, et al. "Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2." Proceedings of the National Academy of Sciences 118.12 (2021).
05-06-2021Read More »